17768-34-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-1-adamantaneacetic acid is utilized as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique structure and properties make it a valuable component in the development of new medications, particularly those targeting specific biological pathways or diseases.
Used in Cancer Research:
In the field of oncology, 3-Bromo-1-adamantaneacetic acid is employed as a research tool to study its potential as an anticancer agent. Its ability to inhibit the growth of cancer cells positions it as a candidate for further investigation into its therapeutic efficacy and possible integration into cancer treatment protocols.
Used in Organic Chemistry:
3-Bromo-1-adamantaneacetic acid serves as a versatile intermediate in organic chemistry for the production of a range of organic compounds and materials. Its stability and reactivity make it suitable for use in various chemical reactions, contributing to the synthesis of specialty chemicals and advanced materials.
Used in Research and Development:
Due to its unique chemical properties, 3-Bromo-1-adamantaneacetic acid is used in research and development settings to explore new applications and understand its interactions with biological systems. This includes its potential use in drug discovery, material science, and the development of novel chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 17768-34-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,7,6 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 17768-34:
(7*1)+(6*7)+(5*7)+(4*6)+(3*8)+(2*3)+(1*4)=142
142 % 10 = 2
So 17768-34-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H17BrO2/c13-12-4-8-1-9(5-12)3-11(2-8,7-12)6-10(14)15/h8-9H,1-7H2,(H,14,15)/p-1/t8-,9-,11?,12?/m1/s1
17768-34-2Relevant academic research and scientific papers
Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies
?ilhár, Peter,Silvaggi, Nicholas R.,Pellett, Sabine,?apková, Kate?ina,Johnson, Eric A.,Allen, Karen N.,Janda, Kim D.
supporting information, p. 1344 - 1348 (2013/03/14)
Botulinum neurotoxins (BoNTs) are the most lethal biotoxins known to mankind and are responsible for the neuroparalytic disease botulism. Current treatments for botulinum poisoning are all protein based and thus have a limited window of treatment opportun
FUNCTIONALIZATION OF CARBOXYLIC ACIDS OF THE ADAMANTANE AND BICYCLONONANE SERIES IN LIQUID BROMINE
Baklan, V. F.,Khil'chevskii, A. N.,Sologub, L. S.,Kukhar, V. P.
, p. 1680 - 1683 (2007/10/02)
Carboxylic acids of the adamantane and bicyclononane series react with nucleophilic reagents such as water or acetic acid in liquid bromine to give the corresponding hydroxy, acetoxy, and bromino derivatives.
Synthese de quelques structures encombrees derivees de l'adamantane et de ses analogues par alkylation des ether d'enol trimethylsilyliques
Dubois, Jacques-Emile,Lebbar, Kadija,Lion, Claude,Dugast, Jean-Yves
, p. 905 - 910 (2007/10/02)
Alkylation of trimethylsilyl enol ethers of 2,4-dimethyl-3-pentanone, cyclopentanone and cyclohexanone has been extended to alkylating agents with a cage structure (substituted or functionalized adamantyl, diamantyl, homoadamantyl and noradamantyl chlorides or bromides).This method affords some new cage structured aliphatic and alicyclic ketones.In some cases one observes a new TiCl4 promoted reaction where the bromine in the alkylating agent is replaced by chlorine.This work is a generalization of our previous extended studies on α-alkylation of ketones with tertiary alkylating agents.
